.Just five months after protecting a $one hundred million IPO, Vast Bio is actually actually giving ...
.The initial phases of oncology R&D may not be except appealing brand new methods, and also Halda...
.Psychopharmacology has drawn 3 posts about midstage professional test information analyzing Lykos T...
.Avidity Biosciences amazed investors with phase 1/2 records in Duchenne muscular dystrophy (DMD) Fr...
.Actinogen Medical's cortisol blocker has actually skipped the primary endpoint of a stage 2 study i...
.Antibody-drug conjugates (ADCs) have actually been at the facility of a lot of a billion-dollar bio...
.Possession manager TPG, which has supported biotechs like Sionna Therapies as well as Santa Clam An...
.Merck & Co.'s TIGIT program has gone through another problem. Months after shuttering a stage 3 ...
.After a year determined by pipeline cuts, the departure of its own chief executive officer as well ...
.Cullinan Therapeutics was impressed enough with Harbour BioMed's bispecific invulnerable activator ...